NCT04139304 2025-06-29A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaAIDS Malignancy ConsortiumPhase EARLY_PHASE1 Recruiting15 enrolled
NCT07026604 2025-06-18CCM-DS01Beijing Tiantan HospitalPhase EARLY_PHASE1 Not yet recruiting10 enrolled
NCT03473730 2025-01-30Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney CancerM.D. Anderson Cancer CenterPhase EARLY_PHASE1 Completed17 enrolled